{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:07:57Z","timestamp":1777410477208,"version":"3.51.4"},"reference-count":15,"publisher":"Wiley","issue":"18","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81430087"],"award-info":[{"award-number":["81430087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673396"],"award-info":[{"award-number":["81673396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872831"],"award-info":[{"award-number":["81872831"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603182"],"award-info":[{"award-number":["81603182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Separation Science"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alarelin, a gonadotropin\u2010releasing hormone analogue, is widely used in China for the treatment of endometriosis and uterine leiomyoma. In order to investigate its pharmacokinetic behavior and support the preclinical application of new formulations, we have developed a novel and highly selective bioanalytical method to determine alarelin in rat plasma based on liquid chromatography tandem mass spectrometry with triple stage fragmentation. After sample preparation by protein precipitation followed by reversed phase solid phase extraction, alarelin and triptorelin (internal standard) were chromatographed on an Ascentis<jats:sup>\u00ae<\/jats:sup> Express C18 column (50\u00a0mm \u00d7 4.6\u00a0mm, 2.7\u00a0\u00b5m) using gradient elution with 0.1% formic acid in water and acetonitrile at a flow rate of 1\u00a0mL\/min. Detection was by positive mode electrospray ionization followed by triple stage fragmentation using the transitions at <jats:italic>m\/z<\/jats:italic> 584.6\u2192249.1\u2192221.0 for alarelin and 656.5\u2192249.1\u2192176.0 for triptorelin, The assay was linear in the concentration range 0.3\u201010\u00a0ng\/mL with excellent precision and accuracy. It was successfully applied to a pharmacokinetic study in rats administered a dose of 13.5\u00a0\u00b5g\/kg alarelin by intramuscular injection. The results show that the triple stage fragmentation strategy allows highly selective analysis of alarelin and has the potential to be widely applied to the bioassay of other peptidic drugs.<\/jats:p>","DOI":"10.1002\/jssc.201900359","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T02:38:05Z","timestamp":1561948685000},"page":"3033-3040","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Liquid chromatography tandem mass spectrometry with triple stage fragmentation for highly selective analysis and pharmacokinetics of alarelin in rat plasma"],"prefix":"10.1002","volume":"42","author":[{"given":"Zhi","family":"Zhang","sequence":"first","affiliation":[{"name":"College of Life Science Jilin University  Changchun P. R. China"},{"name":"Beijing Institute of Drug Metabolism  Beijing P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runzhi","family":"Li","sequence":"additional","affiliation":[{"name":"College of Life Science Jilin University  Changchun P. R. China"},{"name":"Beijing Institute of Drug Metabolism  Beijing P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Shengjing Hospital of China Medical University  Shenyang P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8068-5999","authenticated-orcid":false,"given":"Lei","family":"Yin","sequence":"additional","affiliation":[{"name":"College of Life Science Jilin University  Changchun P. R. China"},{"name":"Research Institute of Translational Medicine The First Bethune Hospital of Jilin University  Changchun P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongtong","family":"Xu","sequence":"additional","affiliation":[{"name":"Changchun Center for Drug and Food Control  Changchun P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Paul","family":"Fawcett","sequence":"additional","affiliation":[{"name":"College of Life Science Jilin University  Changchun P. R. China"},{"name":"Beijing Institute of Drug Metabolism  Beijing P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4731-6649","authenticated-orcid":false,"given":"Jingkai","family":"Gu","sequence":"additional","affiliation":[{"name":"College of Life Science Jilin University  Changchun P. R. China"},{"name":"Beijing Institute of Drug Metabolism  Beijing P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/asj.12030"},{"key":"e_1_2_8_3_1","first-page":"611","article-title":"Comparison of alarelin and triptorelin in the long\u2010protocol ovulation induction in in vitro fertilization and embryo transfer","volume":"16","author":"Duan J. L.","year":"2010","journal-title":"Zhonghua Nan Ke Xue"},{"key":"e_1_2_8_4_1","article-title":"Ovarian suppression with gonadotropin\u2010releasing hormone analogues (Gn\u2010RH) in high risk premenopausal breast cancer patients (PM\u2010HR\u2010BC): Decrease of T regulatory cells (T\u2010regs) and of vascular endothelial growth factor (VEGF)","author":"Recchia F.","journal-title":"Cancer Res"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i12.1780"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201500555"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-017-0348-0"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-017-0604-3"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201701182"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201601141"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2012.02.021"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.12.039"},{"key":"e_1_2_8_13_1","first-page":"147","article-title":"Imatinib quantification in human serum with LC\u2010MS3 as an effective way of protein kinase inhibitor analysis in biological matrices","volume":"32","author":"Dziadosz M.","year":"2017","journal-title":"Drug Metab. Pers. Ther."},{"key":"e_1_2_8_14_1","volume-title":"Guidance for Industry: Bioanalytical Method Validation","author":"Food and Drug Administration","year":"2013"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.01.023"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.08.023"}],"container-title":["Journal of Separation Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjssc.201900359","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jssc.201900359","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jssc.201900359","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jssc.201900359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:48:08Z","timestamp":1760867288000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/jssc.201900359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":15,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1002\/jssc.201900359"],"URL":"https:\/\/doi.org\/10.1002\/jssc.201900359","archive":["Portico"],"relation":{},"ISSN":["1615-9306","1615-9314"],"issn-type":[{"value":"1615-9306","type":"print"},{"value":"1615-9314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"2019-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}